VWR Acquires United Biochemicals
News Jul 05, 2013
Based in Sanborn, New York and founded in 1996, United Biochemicals manufactures and supplies high purity buffers and biochemicals for research, development and manufacturing processes to biotech, pharmaceutical, cell culture media and medical diagnostic industries.
"United Biochemicals is a strong compliment to VWR's growing life sciences portfolio as VWR continues to make strategic investment into our business," said Manuel Brocke-Benz, President and CEO of VWR. "United Biochemicals' manufacturing expertise, combined with VWR's existing platform of chemical manufacturing assets, enhances our current offering to our biotech and pharmaceutical customers and strengthens our position in the industry."
"We are excited to join a trusted, global brand like VWR," shared Fayyaz Hussain, President of United Biochemicals. "This acquisition will allow United Biochemicals to leverage VWR's global sales and marketing organization to grow our business."
Financial details of this acquisition remain confidential.
Human Pluripotent Stem Cells Successfully 3D PrintedNews
A breakthrough in the 3D-printing of human pluripotent stem cells means scientists are one step closer to being able to 3D print human organs and tissues for transplantation therapy.READ MORE
Protein Discovery Could Lead to Better Diagnosis of StressNews
Researchers have found a protein that is present in people while they are in stressful situations. The discovery could lead to identifying new ways to predict, diagnose and treat stress.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE